MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$18,718K
Net Income
-$2,476K
Net Profit Margin
-13.23%
EPS
-$0.08
Unit: Thousand (K) dollars
Revenue Breakdown
Journey
Fortress Biotech Inc
Revenue Breakdown
Revenue from contract with custo...
Revenue from contract with custo...
Revenue from contract with custo...
Others
Revenue Breakdown
Product revenue, net
Journey
Fortress Biotech Inc
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
18,718
16,038
12,196*
17,631
Cost of goods - (excluding amortization of acquired intangible assets)
6,143
6,218
4,883*
5,755
Amortization of acquired intangible assets
969
1,126
1,066*
1,064
Research and development
805
540
-600*
208
Selling, general and administrative
20,807
15,893
12,142*
17,415
Total operating expenses
28,724
23,777
17,491*
24,442
Loss from operations
-10,006
-7,739
-5,295*
-6,811
Interest income
1,581
570
448*
736
Interest expense and financing fee
-
3,368
2,216*
2,742
Gain on sale of priority review voucher, net of expenses
-
158,873
-
-
Change in fair value of partner company derivative liability
-
-7,085
-
-
Loss (gain) on common stock warrant liabilities
-
1
130*
-2
Interest expense and financing fee
1,476
-
-
-
Loss from deconsolidation of subsidiary
82
-
9,675*
-
Other income (expense)
10,741
1,042
-8,837*
17,672
Total other income (expense)
10,928
150,033
-800*
15,664
Income (loss) before income tax expense
922
142,294
-6,095*
8,853
Income tax expense
320
5,132
-698*
26
Net income (loss)
602
137,162
-5,397
8,827
Attributable to non-controlling interests
1,070
26,789
-1,460
2,977
Net income (gain) attributable to fortress
-468
110,373
-3,937
5,850
Preferred a dividends declared and paid and/or cumulated, and fortress' share of subsidiary deemed dividends
2,008
2,008
4,391
2,174
Net income (gain) attributable to common stockholders
-2,476
108,365
-8,328
3,675
Basic EPS
-0.08
3.44
-0.268
0.13
Diluted EPS
-0.08
2.82
-0.375
0.11
Basic Average Shares
31,791,173
31,540,595
31,033,484
27,244,474
Diluted Average Shares
31,791,173
38,412,716
22,232,195
33,100,961
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Other income
(expense)
$10,741K
(17424.19%↑ Y/Y)
Interest income
$1,581K
(154.18%↑ Y/Y)
Loss from
deconsolidation of subsidiary
$82K
(-99.70%↓ Y/Y)
Total other income
(expense)
$10,928K
(-55.97%↓ Y/Y)
Interest expense and
financing fee
$1,476K
(-41.38%↓ Y/Y)
Journey
$18,510K
Fortress Biotech Inc
$208K
Net income (gain)
attributable to common...
-$2,476K
Income (loss) before
income tax expense
$922K
Loss from operations
-$10,006K
(72.57%↑ Y/Y)
Net revenue
$18,718K
(14.04%↑ Y/Y)
Preferred a dividends
declared and paid and/or...
$2,008K
Net income (gain)
attributable to fortress
-$468K
(-103.02%↓ Y/Y)
Net income (loss)
$602K
(105.17%↑ Y/Y)
Income tax expense
$320K
Total operating
expenses
$28,724K
(-45.69%↓ Y/Y)
Attributable to
non-controlling interests
$1,070K
(103.94%↑ Y/Y)
Selling, general and
administrative
$20,807K
(-46.31%↓ Y/Y)
Cost of goods -
(excluding amortization of...
$6,143K
(24.38%↑ Y/Y)
Amortization of acquired
intangible assets
$969K
(-8.93%↓ Y/Y)
Research and development
$805K
(-90.09%↓ Y/Y)
Buy us a coffee
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (FBIO)